These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22283814)

  • 1. Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors.
    Jackson ER; Dowd CS
    Curr Top Med Chem; 2012; 12(7):706-28. PubMed ID: 22283814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
    Perruchon J; Ortmann R; Altenkämper M; Silber K; Wiesner J; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1232-41. PubMed ID: 18470849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse
    Abdullaziz MA; Takada S; Illarionov B; Pessanha de Carvalho L; Sakamoto Y; Höfmann S; Knak T; Kiffe-Delf AL; Mazzone F; Pfeffer K; Kalscheuer R; Bacher A; Held J; Fischer M; Tanaka N; Kurz T
    ACS Infect Dis; 2024 May; 10(5):1739-1752. PubMed ID: 38647213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
    Proteau PJ
    Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Woo YH; Fernandes RP; Proteau PJ
    Bioorg Med Chem; 2006 Apr; 14(7):2375-85. PubMed ID: 16310360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Mercklé L; de Andrés-Gómez A; Dick B; Cox RJ; Godfrey CR
    Chembiochem; 2005 Oct; 6(10):1866-74. PubMed ID: 16116659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Andaloussi M; Henriksson LM; Więckowska A; Lindh M; Björkelid C; Larsson AM; Suresh S; Iyer H; Srinivasa BR; Bergfors T; Unge T; Mowbray SL; Larhed M; Jones TA; Karlén A
    J Med Chem; 2011 Jul; 54(14):4964-76. PubMed ID: 21678907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
    Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation.
    Brücher K; Illarionov B; Held J; Tschan S; Kunfermann A; Pein MK; Bacher A; Gräwert T; Maes L; Mordmüller B; Fischer M; Kurz T
    J Med Chem; 2012 Jul; 55(14):6566-75. PubMed ID: 22731758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate analogs for the investigation of deoxyxylulose 5-phosphate reductoisomerase inhibition: synthesis and evaluation.
    Phaosiri C; Proteau PJ
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5309-12. PubMed ID: 15454217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residues.
    Ortmann R; Wiesner J; Silber K; Klebe G; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2007 Sep; 340(9):483-90. PubMed ID: 17806130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr).
    Humnabadkar V; Jha RK; Ghatnekar N; De Sousa SM
    J Biomol Screen; 2011 Mar; 16(3):303-12. PubMed ID: 21335601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoprenoid biosynthesis via the methylerythritol phosphate pathway: structural variations around phosphonate anchor and spacer of fosmidomycin, a potent inhibitor of deoxyxylulose phosphate reductoisomerase.
    Zinglé C; Kuntz L; Tritsch D; Grosdemange-Billiard C; Rohmer M
    J Org Chem; 2010 May; 75(10):3203-7. PubMed ID: 20429517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Deng L; Sundriyal S; Rubio V; Shi ZZ; Song Y
    J Med Chem; 2009 Nov; 52(21):6539-42. PubMed ID: 19888756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.
    Uh E; Jackson ER; San Jose G; Maddox M; Lee RE; Lee RE; Boshoff HI; Dowd CS
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6973-6. PubMed ID: 22024034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
    Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
    Andaloussi M; Lindh M; Björkelid C; Suresh S; Wieckowska A; Iyer H; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5403-7. PubMed ID: 21824775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Chofor R; Sooriyaarachchi S; Risseeuw MD; Bergfors T; Pouyez J; Johny C; Haymond A; Everaert A; Dowd CS; Maes L; Coenye T; Alex A; Couch RD; Jones TA; Wouters J; Mowbray SL; Van Calenbergh S
    J Med Chem; 2015 Apr; 58(7):2988-3001. PubMed ID: 25781377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme.
    Singh N; Chevé G; Avery MA; McCurdy CR
    Curr Pharm Des; 2007; 13(11):1161-77. PubMed ID: 17430177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The malarial drug target Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (PfDXR): development of a 3-D model for identification of novel, structural and functional features and for inhibitor screening.
    Goble JL; Adendorff MR; de Beer TA; Stephens LL; Blatch GL
    Protein Pept Lett; 2010 Jan; 17(1):109-20. PubMed ID: 20214634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.